- Home
- ZEPP vs INO Comparison
ZEPP vs INO Comparison
Compare ZEPP & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZEPP | INO |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | Netherlands | United States |
| Employees | 763 | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.0M | 114.0M |
| IPO Year | 2017 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ZEPP | INO |
|---|---|---|
| Price | $8.64 | $1.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 87.7K | ★ 3.4M |
| Earning Date | 05-18-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | $778.34 | $20,156.19 |
| Revenue Next Year | N/A | $421.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $2.25 | $1.03 |
| 52 Week High | $61.50 | $2.86 |
Technical Indicators
Market Signals| Indicator | ZEPP | INO |
|---|---|---|
| Relative Strength Index (RSI) | 31.15 | 55.87 |
| Support Level | N/A | $1.03 |
| Resistance Level | $30.26 | $1.79 |
| Average True Range (ATR) | 1.55 | 0.16 |
| MACD | -0.53 | 0.01 |
| Stochastic Oscillator | 0.40 | 34.85 |
Price Performance
Historical ComparisonAbout ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.